Your browser doesn't support javascript.
loading
Hyperglycaemic disorders associated with PCSK9 inhibitors: a real-world, pharmacovigilance study.
Goldman, Adam; Raschi, Emanuel; Cukierman-Yaffe, Tali; Dankner, Rachel; Shouval, Roni; Shechter, Michael; Ben-Zvi, Ilan; Gerstein, Hertzel C; Maor, Elad.
Afiliación
  • Goldman A; Sackler Faculty of Medicine, Tel-Aviv University, Ramat Aviv, Tel Aviv 69978, Israel.
  • Raschi E; Leviev Heart Center, Sheba Medical Center, Derech Sheba 2, Ramat Gan, Israel.
  • Cukierman-Yaffe T; Department of Internal Medicine, Sheba Medical Center, Derech Sheba 2, Ramat Gan, Israel.
  • Dankner R; Pharmacology Unit, Department of Medical and Surgical Sciences, Alma Mater Studiorum, University of Bologna, Bologna, Italy.
  • Shouval R; Division of Endocrinology & Metabolism, Sheba Medical Center, Derech Sheba 2, Ramat Gan, Israel.
  • Shechter M; Department of Epidemiology and Preventive Medicine, School of Public Health, Sackler School of Medicine, Tel Aviv University, Ramat Aviv, Tel Aviv 69978, Israel.
  • Ben-Zvi I; Department of Epidemiology and Preventive Medicine, School of Public Health, Sackler School of Medicine, Tel Aviv University, Ramat Aviv, Tel Aviv 69978, Israel.
  • Gerstein HC; Unit for Cardiovascular Epidemiology, The Gertner Institute for Epidemiology and Health Policy Research, Sheba Medical Center, Derech Sheba 2, Ramat Gan, Israel.
  • Maor E; Adult Bone Marrow Transplantation Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Eur J Prev Cardiol ; 29(9): 1334-1342, 2022 07 20.
Article en En | MEDLINE | ID: mdl-34897409
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Inhibidores de PCSK9 / Hiperglucemia Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Eur J Prev Cardiol Año: 2022 Tipo del documento: Article País de afiliación: Israel
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Inhibidores de PCSK9 / Hiperglucemia Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Eur J Prev Cardiol Año: 2022 Tipo del documento: Article País de afiliación: Israel